Azurity Pharmaceuticals 召回 Zenzedi ADHD 和发作性睡病药物，因为可能存在马来酸卡宾沙明混淆，对患者健康构成风险。 Azurity Pharmaceuticals recalls Zenzedi ADHD & narcolepsy medication due to potential carbinoxamine maleate mix-up, posing risks to patients' health.
一家制药公司正在召回治疗多动症（注意力缺陷多动症）和发作性睡病的药物，因为该药物的包装可能含有错误的药片。 A pharmaceutical company is recalling medication for ADHD (attention deficit hyperactivity disorder) and narcolepsy because packages of the drug may contain the wrong pills. 内布拉斯加州的一名药剂师打开一瓶 Zenzedi 药片，发现含有马来酸卡比沙明（一种抗组胺药）的片剂，导致该产品被召回。 The product is being recalled after a pharmacist in Nebraska opened a bottle of Zenzedi tablets and found tablets of Carbinoxamine Maleate, an antihistamine drug. 此次召回的原因是药物混淆，一些瓶子中发现了错误的药片，可能使患者面临发生事故或受伤的风险。 The recall is due to a mix-up in the medications, with the wrong pills found in some bottles, potentially putting patients at risk of getting into accidents or injuring themselves.